Effects of Serotonin 2C Receptor Agonists on the Behavioral and Neurochemical Effects of Cocaine in Squirrel Monkeys
Accumulating evidence indicates that the serotonin system modulates the behavioral and neurochemical effects of cocaine, but the receptor subtypes mediating these effects remain unknown. Recent studies have demonstrated that pharmacological activation of the serotonin 2C receptor (5-HT2CR) attenuate...
Saved in:
| Published in | The Journal of pharmacology and experimental therapeutics Vol. 341; no. 2; pp. 424 - 434 |
|---|---|
| Main Authors | , , |
| Format | Journal Article |
| Language | English |
| Published |
Netherlands
Elsevier Inc
01.05.2012
The American Society for Pharmacology and Experimental Therapeutics |
| Subjects | |
| Online Access | Get full text |
| ISSN | 0022-3565 1521-0103 1521-0103 |
| DOI | 10.1124/jpet.111.186981 |
Cover
Loading…
| Abstract | Accumulating evidence indicates that the serotonin system modulates the behavioral and neurochemical effects of cocaine, but the receptor subtypes mediating these effects remain unknown. Recent studies have demonstrated that pharmacological activation of the serotonin 2C receptor (5-HT2CR) attenuates the behavioral and neurochemical effects of cocaine in rodents, but such compounds have not been systematically evaluated in nonhuman primates. The present experiments sought to determine the impact of pretreatment with the preferential 5-HT2CR agonist m-chlorophenylpiperazine (mCPP) and the selective 5-HT2CR agonist Ro 60-0175 [(α-S)-6-chloro-5-fluoro-α-methyl-1H-indole-1-ethanamine fumarate] on the behavioral and neurochemical effects of cocaine in squirrel monkeys. In subjects trained to lever-press according to a 300-s fixed-interval schedule of stimulus termination, pretreatment with either 5-HT2CR agonist dose-dependently and insurmountably attenuated the behavioral stimulant effects of cocaine. In subjects trained to self-administer cocaine, both compounds dose-dependently and insurmountably attenuated cocaine-induced reinstatement of previously extinguished responding in an antagonist-reversible manner, and the selective agonist Ro 60-0175 also attenuated the reinforcing effects of cocaine during ongoing cocaine self-administration. It is noteworthy that the selective agonist Ro 60-0175 exhibited behavioral specificity because it did not significantly alter nondrug-maintained responding. Finally, in vivo microdialysis studies revealed that pretreatment with Ro 60-0175 caused a reduction of cocaine-induced dopamine increases within the nucleus accumbens, but not the caudate nucleus. These results suggest that 5-HT2CR agonists functionally antagonize the behavioral effects of cocaine in nonhuman primates, possibly via a selective modulation of cocaine-induced dopamine increases within the mesolimbic dopamine system and may therefore represent a novel class of pharmacotherapeutics for the treatment of cocaine abuse. |
|---|---|
| AbstractList | Accumulating evidence indicates that the serotonin system modulates the behavioral and neurochemical effects of cocaine, but the receptor subtypes mediating these effects remain unknown. Recent studies have demonstrated that pharmacological activation of the serotonin 2C receptor (5-HT
2C
R) attenuates the behavioral and neurochemical effects of cocaine in rodents, but such compounds have not been systematically evaluated in nonhuman primates. The present experiments sought to determine the impact of pretreatment with the preferential 5-HT
2C
R agonist
m
-chlorophenylpiperazine (mCPP) and the selective 5-HT
2C
R agonist Ro 60-0175 [(α-
S
)-6-chloro-5-fluoro-α-methyl-1
H
-indole-1-ethanamine fumarate] on the behavioral and neurochemical effects of cocaine in squirrel monkeys. In subjects trained to lever-press according to a 300-s fixed-interval schedule of stimulus termination, pretreatment with either 5-HT
2C
R agonist dose-dependently and insurmountably attenuated the behavioral stimulant effects of cocaine. In subjects trained to self-administer cocaine, both compounds dose-dependently and insurmountably attenuated cocaine-induced reinstatement of previously extinguished responding in an antagonist-reversible manner, and the selective agonist Ro 60-0175 also attenuated the reinforcing effects of cocaine during ongoing cocaine self-administration. It is noteworthy that the selective agonist Ro 60-0175 exhibited behavioral specificity because it did not significantly alter nondrug-maintained responding. Finally, in vivo microdialysis studies revealed that pretreatment with Ro 60-0175 caused a reduction of cocaine-induced dopamine increases within the nucleus accumbens, but not the caudate nucleus. These results suggest that 5-HT
2C
R agonists functionally antagonize the behavioral effects of cocaine in nonhuman primates, possibly via a selective modulation of cocaine-induced dopamine increases within the mesolimbic dopamine system and may therefore represent a novel class of pharmacotherapeutics for the treatment of cocaine abuse. Accumulating evidence indicates that the serotonin system modulates the behavioral and neurochemical effects of cocaine, but the receptor subtypes mediating these effects remain unknown. Recent studies have demonstrated that pharmacological activation of the serotonin 2C receptor (5-HT2CR) attenuates the behavioral and neurochemical effects of cocaine in rodents, but such compounds have not been systematically evaluated in nonhuman primates. The present experiments sought to determine the impact of pretreatment with the preferential 5-HT2CR agonist m-chlorophenylpiperazine (mCPP) and the selective 5-HT2CR agonist Ro 60-0175 [(α-S)-6-chloro-5-fluoro-α-methyl-1H-indole-1-ethanamine fumarate] on the behavioral and neurochemical effects of cocaine in squirrel monkeys. In subjects trained to lever-press according to a 300-s fixed-interval schedule of stimulus termination, pretreatment with either 5-HT2CR agonist dose-dependently and insurmountably attenuated the behavioral stimulant effects of cocaine. In subjects trained to self-administer cocaine, both compounds dose-dependently and insurmountably attenuated cocaine-induced reinstatement of previously extinguished responding in an antagonist-reversible manner, and the selective agonist Ro 60-0175 also attenuated the reinforcing effects of cocaine during ongoing cocaine self-administration. It is noteworthy that the selective agonist Ro 60-0175 exhibited behavioral specificity because it did not significantly alter nondrug-maintained responding. Finally, in vivo microdialysis studies revealed that pretreatment with Ro 60-0175 caused a reduction of cocaine-induced dopamine increases within the nucleus accumbens, but not the caudate nucleus. These results suggest that 5-HT2CR agonists functionally antagonize the behavioral effects of cocaine in nonhuman primates, possibly via a selective modulation of cocaine-induced dopamine increases within the mesolimbic dopamine system and may therefore represent a novel class of pharmacotherapeutics for the treatment of cocaine abuse. Accumulating evidence indicates that the serotonin system modulates the behavioral and neurochemical effects of cocaine, but the receptor subtypes mediating these effects remain unknown. Recent studies have demonstrated that pharmacological activation of the serotonin 2C receptor (5-HT(2C)R) attenuates the behavioral and neurochemical effects of cocaine in rodents, but such compounds have not been systematically evaluated in nonhuman primates. The present experiments sought to determine the impact of pretreatment with the preferential 5-HT(2C)R agonist m-chlorophenylpiperazine (mCPP) and the selective 5-HT(2C)R agonist Ro 60-0175 [(α-S)-6-chloro-5-fluoro-α-methyl-1H-indole-1-ethanamine fumarate] on the behavioral and neurochemical effects of cocaine in squirrel monkeys. In subjects trained to lever-press according to a 300-s fixed-interval schedule of stimulus termination, pretreatment with either 5-HT(2C)R agonist dose-dependently and insurmountably attenuated the behavioral stimulant effects of cocaine. In subjects trained to self-administer cocaine, both compounds dose-dependently and insurmountably attenuated cocaine-induced reinstatement of previously extinguished responding in an antagonist-reversible manner, and the selective agonist Ro 60-0175 also attenuated the reinforcing effects of cocaine during ongoing cocaine self-administration. It is noteworthy that the selective agonist Ro 60-0175 exhibited behavioral specificity because it did not significantly alter nondrug-maintained responding. Finally, in vivo microdialysis studies revealed that pretreatment with Ro 60-0175 caused a reduction of cocaine-induced dopamine increases within the nucleus accumbens, but not the caudate nucleus. These results suggest that 5-HT(2C)R agonists functionally antagonize the behavioral effects of cocaine in nonhuman primates, possibly via a selective modulation of cocaine-induced dopamine increases within the mesolimbic dopamine system and may therefore represent a novel class of pharmacotherapeutics for the treatment of cocaine abuse.Accumulating evidence indicates that the serotonin system modulates the behavioral and neurochemical effects of cocaine, but the receptor subtypes mediating these effects remain unknown. Recent studies have demonstrated that pharmacological activation of the serotonin 2C receptor (5-HT(2C)R) attenuates the behavioral and neurochemical effects of cocaine in rodents, but such compounds have not been systematically evaluated in nonhuman primates. The present experiments sought to determine the impact of pretreatment with the preferential 5-HT(2C)R agonist m-chlorophenylpiperazine (mCPP) and the selective 5-HT(2C)R agonist Ro 60-0175 [(α-S)-6-chloro-5-fluoro-α-methyl-1H-indole-1-ethanamine fumarate] on the behavioral and neurochemical effects of cocaine in squirrel monkeys. In subjects trained to lever-press according to a 300-s fixed-interval schedule of stimulus termination, pretreatment with either 5-HT(2C)R agonist dose-dependently and insurmountably attenuated the behavioral stimulant effects of cocaine. In subjects trained to self-administer cocaine, both compounds dose-dependently and insurmountably attenuated cocaine-induced reinstatement of previously extinguished responding in an antagonist-reversible manner, and the selective agonist Ro 60-0175 also attenuated the reinforcing effects of cocaine during ongoing cocaine self-administration. It is noteworthy that the selective agonist Ro 60-0175 exhibited behavioral specificity because it did not significantly alter nondrug-maintained responding. Finally, in vivo microdialysis studies revealed that pretreatment with Ro 60-0175 caused a reduction of cocaine-induced dopamine increases within the nucleus accumbens, but not the caudate nucleus. These results suggest that 5-HT(2C)R agonists functionally antagonize the behavioral effects of cocaine in nonhuman primates, possibly via a selective modulation of cocaine-induced dopamine increases within the mesolimbic dopamine system and may therefore represent a novel class of pharmacotherapeutics for the treatment of cocaine abuse. Accumulating evidence indicates that the serotonin system modulates the behavioral and neurochemical effects of cocaine, but the receptor subtypes mediating these effects remain unknown. Recent studies have demonstrated that pharmacological activation of the serotonin 2C receptor (5-HT(2C)R) attenuates the behavioral and neurochemical effects of cocaine in rodents, but such compounds have not been systematically evaluated in nonhuman primates. The present experiments sought to determine the impact of pretreatment with the preferential 5-HT(2C)R agonist m-chlorophenylpiperazine (mCPP) and the selective 5-HT(2C)R agonist Ro 60-0175 [(α-S)-6-chloro-5-fluoro-α-methyl-1H-indole-1-ethanamine fumarate] on the behavioral and neurochemical effects of cocaine in squirrel monkeys. In subjects trained to lever-press according to a 300-s fixed-interval schedule of stimulus termination, pretreatment with either 5-HT(2C)R agonist dose-dependently and insurmountably attenuated the behavioral stimulant effects of cocaine. In subjects trained to self-administer cocaine, both compounds dose-dependently and insurmountably attenuated cocaine-induced reinstatement of previously extinguished responding in an antagonist-reversible manner, and the selective agonist Ro 60-0175 also attenuated the reinforcing effects of cocaine during ongoing cocaine self-administration. It is noteworthy that the selective agonist Ro 60-0175 exhibited behavioral specificity because it did not significantly alter nondrug-maintained responding. Finally, in vivo microdialysis studies revealed that pretreatment with Ro 60-0175 caused a reduction of cocaine-induced dopamine increases within the nucleus accumbens, but not the caudate nucleus. These results suggest that 5-HT(2C)R agonists functionally antagonize the behavioral effects of cocaine in nonhuman primates, possibly via a selective modulation of cocaine-induced dopamine increases within the mesolimbic dopamine system and may therefore represent a novel class of pharmacotherapeutics for the treatment of cocaine abuse. |
| Author | Howell, Leonard L. Kimmel, Heather L. Manvich, Daniel F. |
| Author_xml | – sequence: 1 givenname: Daniel F. surname: Manvich fullname: Manvich, Daniel F. – sequence: 2 givenname: Heather L. surname: Kimmel fullname: Kimmel, Heather L. – sequence: 3 givenname: Leonard L. surname: Howell fullname: Howell, Leonard L. email: leonard@rmy.emory.edu |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/22328576$$D View this record in MEDLINE/PubMed |
| BookMark | eNp1UV1LHDEUDcVSV9vnvpU89mU0N5mZnXkR7OIXaAVtn0M2uXGjs8maZBb892ZZLVYQArncnI9wzh7Z8cEjId-BHQDw-vB-hblMcABd23fwiUyg4VAxYGKHTBjjvBJN2-ySvZTuGYO6bsUXssu54F0zbSckn1iLOicaLL3FGHLwzlM-ozeocZVDpMd3ZZU2CE_zAukvXKi1C1ENVHlDf-MYg17g0umyeaM2C1o5j7TI3T6OLkYc6FXwD_iUvpLPVg0Jv73c--Tv6cmf2Xl1eX12MTu-rHRdi1z1ymhea5gL0CAaZLa35SjGjDKdsFzZXvGpAoMg7JwZBtDWzdyUCNppx8U-Odrqrsb5Eo1Gn8u35Sq6pYpPMign_3_xbiHvwloKIdoOuiLw80UghscRU5ZLlzQOg_IYxiShRNq3U2hEgf546_XP5DXqAmi2AB1DShGt1C6r7MLG2g1FS24qlZtKywRyW2nhHb7jvUp_zOi3DCzZrh1GmbRDr9G4WNqRJrgPuc8w87lw |
| CitedBy_id | crossref_primary_10_1007_s40473_022_00246_z crossref_primary_10_2174_1568026619666190709101449 crossref_primary_10_1002_jeab_744 crossref_primary_10_1177_0269881113492898 crossref_primary_10_1016_j_ejphar_2018_09_025 crossref_primary_10_1038_npp_2017_124 crossref_primary_10_1016_j_pharmthera_2015_11_009 crossref_primary_10_1007_s43440_022_00428_2 crossref_primary_10_1124_jpet_116_236307 crossref_primary_10_1177_0269881116677104 crossref_primary_10_1371_journal_pone_0254724 crossref_primary_10_1038_npp_2016_63 crossref_primary_10_1517_17460441_2014_959925 crossref_primary_10_1111_adb_12137 crossref_primary_10_1016_j_neuropharm_2022_109150 crossref_primary_10_1155_2015_846589 crossref_primary_10_3389_fphar_2018_00561 crossref_primary_10_1016_j_neuropharm_2014_10_016 crossref_primary_10_1016_j_neuropharm_2017_12_023 crossref_primary_10_1021_acschemneuro_5b00025 crossref_primary_10_1021_acsmedchemlett_7b00443 crossref_primary_10_1124_pr_118_015552 crossref_primary_10_12677_AP_2020_102019 crossref_primary_10_1016_j_vascn_2013_06_002 crossref_primary_10_1007_s00702_018_1878_0 crossref_primary_10_1021_acschemneuro_6b00413 crossref_primary_10_1124_pr_114_009514 crossref_primary_10_1016_j_celrep_2023_112404 crossref_primary_10_1097_FBP_0000000000000339 crossref_primary_10_1007_s00213_015_3982_2 crossref_primary_10_1124_jpet_113_212357 crossref_primary_10_1016_j_neuropharm_2019_107848 crossref_primary_10_1038_s41386_018_0200_z crossref_primary_10_1038_npp_2016_259 crossref_primary_10_1007_s00213_015_3932_z crossref_primary_10_1016_j_drugalcdep_2018_10_018 crossref_primary_10_1111_bph_12735 crossref_primary_10_1007_s00221_013_3508_2 crossref_primary_10_1016_j_bbr_2014_04_007 crossref_primary_10_1016_j_brainres_2017_07_016 crossref_primary_10_1038_tp_2013_131 crossref_primary_10_1016_j_neuropharm_2015_09_028 crossref_primary_10_1007_s00213_017_4545_5 crossref_primary_10_1124_jpet_117_246082 crossref_primary_10_3389_fpsyt_2021_666945 crossref_primary_10_1016_j_neuropharm_2020_108009 crossref_primary_10_1016_j_drugalcdep_2017_09_008 crossref_primary_10_1007_s00894_014_2120_0 crossref_primary_10_1016_j_bbr_2012_11_030 crossref_primary_10_1177_0269881117735797 crossref_primary_10_1016_j_tips_2013_08_001 crossref_primary_10_1007_s00213_017_4653_2 crossref_primary_10_1016_j_neuroimage_2013_08_035 crossref_primary_10_1038_npp_2016_280 crossref_primary_10_1124_jpet_115_228833 |
| Cites_doi | 10.1097/00004714-199412000-00005 10.1159/000191473 10.1097/00001756-199704140-00006 10.1111/j.1460-9568.2011.07621.x 10.1016/S0079-6123(08)00916-3 10.1007/s00213-002-1157-4 10.1016/S0028-3908(99)00047-7 10.1037/0735-7044.118.1.157 10.1002/(SICI)1098-2396(200001)35:1<53::AID-SYN7>3.0.CO;2-2 10.1124/jpet.300.3.831 10.1007/s00213-009-1705-2 10.1016/j.neuroscience.2006.12.071 10.1124/jpet.104.068841 10.1007/s00213-007-0916-7 10.1038/sj.npp.1301414 10.1002/(SICI)1096-9861(19970728)384:2<233::AID-CNE5>3.0.CO;2-2 10.1097/FBP.0b013e3282f1c94b 10.1016/S0306-4522(00)00561-3 10.1016/S0022-3565(25)20686-3 10.1038/sj.npp.1301509 10.1124/jpet.106.107383 10.1007/s00213-009-1545-0 10.1016/S0022-3565(24)39021-4 10.1016/0024-3205(90)90132-B 10.1016/j.pbb.2005.01.004 10.1016/S0022-3565(25)12217-9 10.1016/j.pbb.2009.09.007 10.1038/sj.bjp.0702751 10.1007/s002130050210 10.1038/nrn1406 10.1016/S0022-3565(25)20689-9 10.1126/science.2820058 10.1002/syn.20135 10.1002/syn.1095 10.1016/j.pbb.2009.08.011 10.1016/j.pbb.2006.12.006 10.1124/jpet.110.166595 10.1038/386827a0 10.1016/0028-3908(93)90034-Z 10.1007/s002130050054 10.1016/S0091-3057(99)00049-0 10.1016/S0022-3565(25)10686-1 10.1016/S0893-133X(98)00070-0 10.1016/0376-8716(93)90067-Z |
| ContentType | Journal Article |
| Copyright | 2012 American Society for Pharmacology and Experimental Therapeutics Copyright © 2012 by The American Society for Pharmacology and Experimental Therapeutics 2012 |
| Copyright_xml | – notice: 2012 American Society for Pharmacology and Experimental Therapeutics – notice: Copyright © 2012 by The American Society for Pharmacology and Experimental Therapeutics 2012 |
| DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 5PM |
| DOI | 10.1124/jpet.111.186981 |
| DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic PubMed Central (Full Participant titles) |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE - Academic MEDLINE |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Pharmacy, Therapeutics, & Pharmacology |
| DocumentTitleAlternate | 5-HT2CR Agonism and Cocaine Effects in Squirrel Monkeys |
| EISSN | 1521-0103 |
| EndPage | 434 |
| ExternalDocumentID | PMC3336818 22328576 10_1124_jpet_111_186981 S0022356524181724 |
| Genre | Journal Article Research Support, American Recovery and Reinvestment Act Research Support, N.I.H., Extramural |
| GrantInformation_xml | – fundername: NIDA NIH HHS grantid: R01 DA012514 – fundername: NCRR NIH HHS grantid: P51 RR000165 – fundername: NIDA NIH HHS grantid: F31 DA026262 – fundername: NCRR NIH HHS grantid: RR00165 – fundername: NIDA NIH HHS grantid: K02 DA000517 – fundername: NIDA NIH HHS grantid: DA12514 – fundername: NIDA NIH HHS grantid: F31-DA026262 – fundername: NIDA NIH HHS grantid: K05 DA031246 – fundername: Intramural NIH HHS grantid: Z01 DA000517 – fundername: NIDA NIH HHS grantid: F31DA026262 – fundername: National Institutes of Health grantid: DA12514; DA00517; F31-DA026262; RR00165 |
| GroupedDBID | --- -~X .55 .GJ 0R~ 18M 2WC 3O- 4.4 53G 5GY 5RE 5VS 8WZ A6W AAXUO AAYOK ABCQX ABIVO ABJNI ABOCM ABSQV ACGFO ACGFS ACNCT ADBBV ADCOW ADIYS AENEX AERNN AETEA AFFNX AFOSN AGFXO AI. ALMA_UNASSIGNED_HOLDINGS BAWUL BTFSW CS3 DIK DU5 E3Z EBS EJD F5P F9R FDB GX1 H13 HZ~ INIJC KQ8 L7B LSO M41 MJL MVM O9- OHT P2P R.V R0Z RHI ROL RPT TR2 UQL VH1 W8F WH7 WOQ X7M YBU YHG YQT ZGI ZXP AALRI AAYXX ACVFH ADCNI AEUPX AFPUW AIGII AKBMS AKYEP CITATION CGR CUY CVF ECM EIF NPM 7X8 5PM |
| ID | FETCH-LOGICAL-c443t-9adc24c1b31c135e0f9ff9fa00dad83f2af9a27a1de13fb0d011645bd52167823 |
| ISSN | 0022-3565 1521-0103 |
| IngestDate | Thu Aug 21 17:52:56 EDT 2025 Fri Jul 11 10:58:18 EDT 2025 Mon Jul 21 06:06:27 EDT 2025 Thu Apr 24 22:55:03 EDT 2025 Tue Jul 01 05:33:26 EDT 2025 Sun Apr 06 06:55:05 EDT 2025 |
| IsDoiOpenAccess | false |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 2 |
| Keywords | NAc VTA mCPP ANOVA SB 242084 veh aCSF FR20 5-HT 5-HT2CR DA Ro 60-0175 |
| Language | English |
| LinkModel | OpenURL |
| MergedId | FETCHMERGED-LOGICAL-c443t-9adc24c1b31c135e0f9ff9fa00dad83f2af9a27a1de13fb0d011645bd52167823 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 ObjectType-Undefined-3 |
| OpenAccessLink | https://jpet.aspetjournals.org/content/jpet/341/2/424.full.pdf |
| PMID | 22328576 |
| PQID | 1001967153 |
| PQPubID | 23479 |
| PageCount | 11 |
| ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_3336818 proquest_miscellaneous_1001967153 pubmed_primary_22328576 crossref_citationtrail_10_1124_jpet_111_186981 crossref_primary_10_1124_jpet_111_186981 elsevier_sciencedirect_doi_10_1124_jpet_111_186981 |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | May 2012 2012-05-00 2012-May 20120501 |
| PublicationDateYYYYMMDD | 2012-05-01 |
| PublicationDate_xml | – month: 05 year: 2012 text: May 2012 |
| PublicationDecade | 2010 |
| PublicationPlace | Netherlands |
| PublicationPlace_xml | – name: Netherlands |
| PublicationTitle | The Journal of pharmacology and experimental therapeutics |
| PublicationTitleAlternate | J Pharmacol Exp Ther |
| PublicationYear | 2012 |
| Publisher | Elsevier Inc The American Society for Pharmacology and Experimental Therapeutics |
| Publisher_xml | – name: Elsevier Inc – name: The American Society for Pharmacology and Experimental Therapeutics |
| References | Ginsburg, Kimmel, Carroll, Goodman, Howell (bib21) 2005; 80 Walsh, Preston, Sullivan, Fromme, Bigelow (bib44) 1994; 14 Grottick, Fletcher, Higgins (bib23) 2000; 295 Baumann, Rutter, Auerbach (bib3) 1993; 32 Eriksson, Engberg, Bing, Nissbrandt (bib16) 1999; 20 Navailles, Moison, Cunningham, Spampinato (bib31) 2008; 33 Negus, Mello, Blough, Baumann, Rothman (bib32) 2007; 320 Ritz, Lamb, Goldberg, Kuhar (bib36) 1987; 237 Spealman, Barrett-Larimore, Rowlett, Platt, Khroyan (bib39) 1999; 64 Walsh, Cunningham (bib43) 1997; 130 Burbassi, Cervo (bib8) 2008; 196 Czoty, Justice, Howell (bib11) 2000; 148 Fletcher, Rizos, Sinyard, Tampakeras, Higgins (bib19) 2008; 33 Kimmel, Ginsburg, Howell (bib25) 2005; 56 Bauzo, Kimmel, Howell (bib4) 2009; 94 Eberle-Wang, Mikeladze, Uryu, Chesselet (bib15) 1997; 384 Fantegrossi, Bauzo, Manvich, Morales, Votaw, Goodman, Howell (bib17) 2009; 205 Di Matteo, Di Giovanni, Di Mascio, Esposito (bib14) 1999; 38 Filip, Bubar, Cunningham (bib18) 2004; 310 Volkow, Wang, Fischman, Foltin, Fowler, Abumrad, Vitkun, Logan, Gatley, Pappas (bib41) 1997; 386 Ritz, Cone, Kuhar (bib35) 1990; 46 Wallman, Gagnon, Parent (bib42) 2011; 33 Wise (bib45) 2004; 5 Schindler, Panlilio, Goldberg (bib38) 2002; 163 Bubar, Cunningham (bib7) 2008; 172 Kimmel, O'Connor, Carroll, Howell (bib27) 2007; 86 Kleven, Woolverton (bib28) 1993; 31 Murnane, Fantegrossi, Godfrey, Banks, Howell (bib30) 2010; 334 Kimmel, Manvich, Blough, Negus, Howell (bib26) 2009; 94 Banks, Manvich, Bauzo, Howell (bib2) 2009; 83 Howell, Byrd (bib24) 1995; 275 Neisewander, Acosta (bib33) 2007; 18 Frankel, Cunningham (bib20) 2004; 118 López-Giménez, Mengod, Palacios, Vilaró (bib29) 2001; 42 Callahan, Cunningham (bib9) 1995; 274 Porter, Benwell, Lamb, Malcolm, Allen, Revell, Adams, Sheardown (bib34) 1999; 128 Di Giovanni, Di Matteo, Di Mascio, Esposito (bib12) 2000; 35 Bergman, Madras, Johnson, Spealman (bib5) 1989; 251 Azmitia, Gannon (bib1) 1986; 43 Glowa, Rice, Matecka, Rothman (bib22) 1997; 8 Spealman, Madras, Bergman (bib40) 1989; 251 Rüedi-Bettschen, Rowlett, Spealman, Platt (bib37) 2010; 210 Czoty, Ginsburg, Howell (bib10) 2002; 300 Bubar, Cunningham (bib6) 2007; 146 Di Giovanni, Di Matteo, La Grutta, Esposito (bib13) 2001; 103 Negus (10.1124/jpet.111.186981_bib32) 2007; 320 Callahan (10.1124/jpet.111.186981_bib9) 1995; 274 Di Matteo (10.1124/jpet.111.186981_bib14) 1999; 38 Wallman (10.1124/jpet.111.186981_bib42) 2011; 33 Di Giovanni (10.1124/jpet.111.186981_bib12) 2000; 35 Grottick (10.1124/jpet.111.186981_bib23) 2000; 295 Ginsburg (10.1124/jpet.111.186981_bib21) 2005; 80 Spealman (10.1124/jpet.111.186981_bib39) 1999; 64 Murnane (10.1124/jpet.111.186981_bib30) 2010; 334 Porter (10.1124/jpet.111.186981_bib34) 1999; 128 Fantegrossi (10.1124/jpet.111.186981_bib17) 2009; 205 Baumann (10.1124/jpet.111.186981_bib3) 1993; 32 Di Giovanni (10.1124/jpet.111.186981_bib13) 2001; 103 Bubar (10.1124/jpet.111.186981_bib6) 2007; 146 Bubar (10.1124/jpet.111.186981_bib7) 2008; 172 Rüedi-Bettschen (10.1124/jpet.111.186981_bib37) 2010; 210 Kimmel (10.1124/jpet.111.186981_bib26) 2009; 94 Czoty (10.1124/jpet.111.186981_bib11) 2000; 148 Walsh (10.1124/jpet.111.186981_bib43) 1997; 130 Banks (10.1124/jpet.111.186981_bib2) 2009; 83 López-Giménez (10.1124/jpet.111.186981_bib29) 2001; 42 Navailles (10.1124/jpet.111.186981_bib31) 2008; 33 Filip (10.1124/jpet.111.186981_bib18) 2004; 310 Schindler (10.1124/jpet.111.186981_bib38) 2002; 163 Bergman (10.1124/jpet.111.186981_bib5) 1989; 251 Ritz (10.1124/jpet.111.186981_bib36) 1987; 237 Czoty (10.1124/jpet.111.186981_bib10) 2002; 300 Wise (10.1124/jpet.111.186981_bib45) 2004; 5 Ritz (10.1124/jpet.111.186981_bib35) 1990; 46 Kleven (10.1124/jpet.111.186981_bib28) 1993; 31 Neisewander (10.1124/jpet.111.186981_bib33) 2007; 18 Walsh (10.1124/jpet.111.186981_bib44) 1994; 14 Kimmel (10.1124/jpet.111.186981_bib27) 2007; 86 Glowa (10.1124/jpet.111.186981_bib22) 1997; 8 Fletcher (10.1124/jpet.111.186981_bib19) 2008; 33 Eberle-Wang (10.1124/jpet.111.186981_bib15) 1997; 384 Bauzo (10.1124/jpet.111.186981_bib4) 2009; 94 Kimmel (10.1124/jpet.111.186981_bib25) 2005; 56 Spealman (10.1124/jpet.111.186981_bib40) 1989; 251 Volkow (10.1124/jpet.111.186981_bib41) 1997; 386 Frankel (10.1124/jpet.111.186981_bib20) 2004; 118 Azmitia (10.1124/jpet.111.186981_bib1) 1986; 43 Eriksson (10.1124/jpet.111.186981_bib16) 1999; 20 Howell (10.1124/jpet.111.186981_bib24) 1995; 275 Burbassi (10.1124/jpet.111.186981_bib8) 2008; 196 |
| References_xml | – volume: 148 start-page: 299 year: 2000 end-page: 306 ident: bib11 article-title: Cocaine-induced changes in extracellular dopamine determined by microdialysis in awake squirrel monkeys publication-title: Psychopharmacology (Berl) – volume: 38 start-page: 1195 year: 1999 end-page: 1205 ident: bib14 article-title: SB 242084, a selective serotonin2C receptor antagonist, increases dopaminergic transmission in the mesolimbic system publication-title: Neuropharmacology – volume: 94 start-page: 204 year: 2009 end-page: 210 ident: bib4 article-title: Interactions between the mGluR2/3 agonist, LY379268, and cocaine on in vivo neurochemistry and behavior in squirrel monkeys publication-title: Pharmacol Biochem Behav – volume: 310 start-page: 1246 year: 2004 end-page: 1254 ident: bib18 article-title: Contribution of serotonin (5-hydroxytryptamine; 5-HT) 5-HT2 receptor subtypes to the hyperlocomotor effects of cocaine: acute and chronic pharmacological analyses publication-title: J Pharmacol Exp Ther – volume: 86 start-page: 45 year: 2007 end-page: 54 ident: bib27 article-title: Faster onset and dopamine transporter selectivity predict stimulant and reinforcing effects of cocaine analogs in squirrel monkeys publication-title: Pharmacol Biochem Behav – volume: 237 start-page: 1219 year: 1987 end-page: 1223 ident: bib36 article-title: Cocaine receptors on dopamine transporters are related to self-administration of cocaine publication-title: Science – volume: 130 start-page: 41 year: 1997 end-page: 58 ident: bib43 article-title: Serotonergic mechanisms involved in the discriminative stimulus, reinforcing and subjective effects of cocaine publication-title: Psychopharmacology (Berl) – volume: 146 start-page: 286 year: 2007 end-page: 297 ident: bib6 article-title: Distribution of serotonin 5-HT2C receptors in the ventral tegmental area publication-title: Neuroscience – volume: 80 start-page: 481 year: 2005 end-page: 491 ident: bib21 article-title: Interaction of cocaine and dopamine transporter inhibitors on behavior and neurochemistry in monkeys publication-title: Pharmacol Biochem Behav – volume: 43 start-page: 407 year: 1986 end-page: 468 ident: bib1 publication-title: Adv Neurol – volume: 118 start-page: 157 year: 2004 end-page: 162 ident: bib20 article-title: -Chlorophenylpiperazine (mCPP) modulates the discriminative stimulus effects of cocaine through actions at the 5-HT2C receptor publication-title: Behav Neurosci – volume: 275 start-page: 1551 year: 1995 end-page: 1559 ident: bib24 article-title: Serotonergic modulation of the behavioral effects of cocaine in the squirrel monkey publication-title: J Pharmacol Exp Ther – volume: 103 start-page: 111 year: 2001 end-page: 116 ident: bib13 article-title: -Chlorophenylpiperazine excites non-dopaminergic neurons in the rat substantia nigra and ventral tegmental area by activating serotonin-2C receptors publication-title: Neuroscience – volume: 20 start-page: 287 year: 1999 end-page: 296 ident: bib16 article-title: Effects of mCPP on the extracellular concentrations of serotonin and dopamine in rat brain publication-title: Neuropsychopharmacology – volume: 5 start-page: 483 year: 2004 end-page: 494 ident: bib45 article-title: Dopamine, learning and motivation publication-title: Nat Rev Neurosci – volume: 172 start-page: 319 year: 2008 end-page: 346 ident: bib7 article-title: Prospects for serotonin 5-HT2R pharmacotherapy in psychostimulant abuse publication-title: Prog Brain Res – volume: 384 start-page: 233 year: 1997 end-page: 247 ident: bib15 article-title: Pattern of expression of the serotonin2C receptor messenger RNA in the basal ganglia of adult rats publication-title: J Comp Neurol – volume: 300 start-page: 831 year: 2002 end-page: 837 ident: bib10 article-title: Serotonergic attenuation of the reinforcing and neurochemical effects of cocaine in squirrel monkeys publication-title: J Pharmacol Exp Ther – volume: 33 start-page: 237 year: 2008 end-page: 246 ident: bib31 article-title: Differential regulation of the mesoaccumbens dopamine circuit by serotonin2C receptors in the ventral tegmental area and the nucleus accumbens: an in vivo microdialysis study with cocaine publication-title: Neuropsychopharmacology – volume: 320 start-page: 627 year: 2007 end-page: 636 ident: bib32 article-title: Monoamine releasers with varying selectivity for dopamine/norepinephrine versus serotonin release as candidate “agonist” medications for cocaine dependence: studies in assays of cocaine discrimination and cocaine self-administration in rhesus monkeys publication-title: J Pharmacol Exp Ther – volume: 295 start-page: 1183 year: 2000 end-page: 1191 ident: bib23 article-title: Studies to investigate the role of 5-HT(2C) receptors on cocaine- and food-maintained behavior publication-title: J Pharmacol Exp Ther – volume: 46 start-page: 635 year: 1990 end-page: 645 ident: bib35 article-title: Cocaine inhibition of ligand binding at dopamine, norepinephrine and serotonin transporters: a structure-activity study publication-title: Life Sci – volume: 83 start-page: 164 year: 2009 end-page: 169 ident: bib2 article-title: Effects of histamine H publication-title: Pharmacology – volume: 251 start-page: 150 year: 1989 end-page: 155 ident: bib5 article-title: Effects of cocaine and related drugs in nonhuman primates. III. Self-administration by squirrel monkeys publication-title: J Pharmacol Exp Ther – volume: 14 start-page: 396 year: 1994 end-page: 407 ident: bib44 article-title: Fluoxetine alters the effects of intravenous cocaine in humans publication-title: J Clin Psychopharmacol – volume: 196 start-page: 15 year: 2008 end-page: 27 ident: bib8 article-title: Stimulation of serotonin2C receptors influences cocaine-seeking behavior in response to drug-associated stimuli in rats publication-title: Psychopharmacology (Berl) – volume: 94 start-page: 278 year: 2009 end-page: 284 ident: bib26 article-title: Behavioral and neurochemical effects of amphetamine analogs that release monoamines in the squirrel monkey publication-title: Pharmacol Biochem Behav – volume: 205 start-page: 337 year: 2009 end-page: 347 ident: bib17 article-title: Role of dopamine transporters in the behavioral effects of 3,4-methylenedioxymethamphetamine (MDMA) in nonhuman primates publication-title: Psychopharmacology (Berl) – volume: 32 start-page: 1381 year: 1993 end-page: 1386 ident: bib3 article-title: -chlorophenylpiperazine (mCPP) increases extracellular serotonin in the diencephalon of awake rats publication-title: Neuropharmacology – volume: 163 start-page: 327 year: 2002 end-page: 344 ident: bib38 article-title: Second-order schedules of drug self-administration in animals publication-title: Psychopharmacology (Berl) – volume: 251 start-page: 142 year: 1989 end-page: 149 ident: bib40 article-title: Effects of cocaine and related drugs in nonhuman primates. II. Stimulant effects on schedule-controlled behavior publication-title: J Pharmacol Exp Ther – volume: 334 start-page: 642 year: 2010 end-page: 650 ident: bib30 article-title: Endocrine and neurochemical effects of 3,4-methylenedioxymethamphetamine and its stereoisomers in rhesus monkeys publication-title: J Pharmacol Exp Ther – volume: 210 start-page: 169 year: 2010 end-page: 177 ident: bib37 article-title: Attenuation of cocaine-induced reinstatement of drug seeking in squirrel monkeys: κ opioid and serotonergic mechanisms publication-title: Psychopharmacology (Berl) – volume: 18 start-page: 791 year: 2007 end-page: 800 ident: bib33 article-title: Stimulation of 5-HT2C receptors attenuates cue and cocaine-primed reinstatement of cocaine-seeking behavior in rats publication-title: Behav Pharmacol – volume: 64 start-page: 327 year: 1999 end-page: 336 ident: bib39 article-title: Pharmacological and environmental determinants of relapse to cocaine-seeking behavior publication-title: Pharmacol Biochem Behav – volume: 386 start-page: 827 year: 1997 end-page: 830 ident: bib41 article-title: Relationship between subjective effects of cocaine and dopamine transporter occupancy publication-title: Nature – volume: 128 start-page: 13 year: 1999 end-page: 20 ident: bib34 article-title: Functional characterization of agonists at recombinant human 5-HT2A, 5-HT2B and 5-HT2C receptors in CHO-K1 cells publication-title: Br J Pharmacol – volume: 274 start-page: 1414 year: 1995 end-page: 1424 ident: bib9 article-title: Modulation of the discriminative stimulus properties of cocaine by 5-HT1B and 5-HT2C receptors publication-title: J Pharmacol Exp Ther – volume: 8 start-page: 1347 year: 1997 end-page: 1351 ident: bib22 article-title: Phentermine/fenfluramine decreases cocaine self-administration in rhesus monkeys publication-title: Neuroreport – volume: 56 start-page: 129 year: 2005 end-page: 134 ident: bib25 article-title: Changes in extracellular dopamine during cocaine self-administration in squirrel monkeys publication-title: Synapse – volume: 31 start-page: 149 year: 1993 end-page: 158 ident: bib28 article-title: Effects of three monoamine uptake inhibitors on behavior maintained by cocaine or food presentation in rhesus monkeys publication-title: Drug Alcohol Depend – volume: 33 start-page: 1519 year: 2011 end-page: 1532 ident: bib42 article-title: Serotonin innervation of human basal ganglia publication-title: Eur J Neurosci – volume: 42 start-page: 12 year: 2001 end-page: 26 ident: bib29 article-title: Regional distribution and cellular localization of 5-HT2C receptor mRNA in monkey brain: comparison with [ publication-title: Synapse – volume: 35 start-page: 53 year: 2000 end-page: 61 ident: bib12 article-title: Preferential modulation of mesolimbic vs. nigrostriatal dopaminergic function by serotonin(2C/2B) receptor agonists: a combined in vivo electrophysiological and microdialysis study publication-title: Synapse – volume: 33 start-page: 1402 year: 2008 end-page: 1412 ident: bib19 article-title: The 5-HT2C receptor agonist Ro60–0175 reduces cocaine self-administration and reinstatement induced by the stressor yohimbine, and contextual cues publication-title: Neuropsychopharmacology – volume: 14 start-page: 396 year: 1994 ident: 10.1124/jpet.111.186981_bib44 article-title: Fluoxetine alters the effects of intravenous cocaine in humans publication-title: J Clin Psychopharmacol doi: 10.1097/00004714-199412000-00005 – volume: 83 start-page: 164 year: 2009 ident: 10.1124/jpet.111.186981_bib2 article-title: Effects of histamine H3 receptor activation on the behavioral-stimulant effects of methamphetamine and cocaine in mice and squirrel monkeys publication-title: Pharmacology doi: 10.1159/000191473 – volume: 8 start-page: 1347 year: 1997 ident: 10.1124/jpet.111.186981_bib22 article-title: Phentermine/fenfluramine decreases cocaine self-administration in rhesus monkeys publication-title: Neuroreport doi: 10.1097/00001756-199704140-00006 – volume: 33 start-page: 1519 year: 2011 ident: 10.1124/jpet.111.186981_bib42 article-title: Serotonin innervation of human basal ganglia publication-title: Eur J Neurosci doi: 10.1111/j.1460-9568.2011.07621.x – volume: 172 start-page: 319 year: 2008 ident: 10.1124/jpet.111.186981_bib7 article-title: Prospects for serotonin 5-HT2R pharmacotherapy in psychostimulant abuse publication-title: Prog Brain Res doi: 10.1016/S0079-6123(08)00916-3 – volume: 163 start-page: 327 year: 2002 ident: 10.1124/jpet.111.186981_bib38 article-title: Second-order schedules of drug self-administration in animals publication-title: Psychopharmacology (Berl) doi: 10.1007/s00213-002-1157-4 – volume: 38 start-page: 1195 year: 1999 ident: 10.1124/jpet.111.186981_bib14 article-title: SB 242084, a selective serotonin2C receptor antagonist, increases dopaminergic transmission in the mesolimbic system publication-title: Neuropharmacology doi: 10.1016/S0028-3908(99)00047-7 – volume: 118 start-page: 157 year: 2004 ident: 10.1124/jpet.111.186981_bib20 article-title: m-Chlorophenylpiperazine (mCPP) modulates the discriminative stimulus effects of cocaine through actions at the 5-HT2C receptor publication-title: Behav Neurosci doi: 10.1037/0735-7044.118.1.157 – volume: 35 start-page: 53 year: 2000 ident: 10.1124/jpet.111.186981_bib12 article-title: Preferential modulation of mesolimbic vs. nigrostriatal dopaminergic function by serotonin(2C/2B) receptor agonists: a combined in vivo electrophysiological and microdialysis study publication-title: Synapse doi: 10.1002/(SICI)1098-2396(200001)35:1<53::AID-SYN7>3.0.CO;2-2 – volume: 300 start-page: 831 year: 2002 ident: 10.1124/jpet.111.186981_bib10 article-title: Serotonergic attenuation of the reinforcing and neurochemical effects of cocaine in squirrel monkeys publication-title: J Pharmacol Exp Ther doi: 10.1124/jpet.300.3.831 – volume: 210 start-page: 169 year: 2010 ident: 10.1124/jpet.111.186981_bib37 article-title: Attenuation of cocaine-induced reinstatement of drug seeking in squirrel monkeys: κ opioid and serotonergic mechanisms publication-title: Psychopharmacology (Berl) doi: 10.1007/s00213-009-1705-2 – volume: 146 start-page: 286 year: 2007 ident: 10.1124/jpet.111.186981_bib6 article-title: Distribution of serotonin 5-HT2C receptors in the ventral tegmental area publication-title: Neuroscience doi: 10.1016/j.neuroscience.2006.12.071 – volume: 310 start-page: 1246 year: 2004 ident: 10.1124/jpet.111.186981_bib18 article-title: Contribution of serotonin (5-hydroxytryptamine; 5-HT) 5-HT2 receptor subtypes to the hyperlocomotor effects of cocaine: acute and chronic pharmacological analyses publication-title: J Pharmacol Exp Ther doi: 10.1124/jpet.104.068841 – volume: 196 start-page: 15 year: 2008 ident: 10.1124/jpet.111.186981_bib8 article-title: Stimulation of serotonin2C receptors influences cocaine-seeking behavior in response to drug-associated stimuli in rats publication-title: Psychopharmacology (Berl) doi: 10.1007/s00213-007-0916-7 – volume: 33 start-page: 237 year: 2008 ident: 10.1124/jpet.111.186981_bib31 article-title: Differential regulation of the mesoaccumbens dopamine circuit by serotonin2C receptors in the ventral tegmental area and the nucleus accumbens: an in vivo microdialysis study with cocaine publication-title: Neuropsychopharmacology doi: 10.1038/sj.npp.1301414 – volume: 384 start-page: 233 year: 1997 ident: 10.1124/jpet.111.186981_bib15 article-title: Pattern of expression of the serotonin2C receptor messenger RNA in the basal ganglia of adult rats publication-title: J Comp Neurol doi: 10.1002/(SICI)1096-9861(19970728)384:2<233::AID-CNE5>3.0.CO;2-2 – volume: 18 start-page: 791 year: 2007 ident: 10.1124/jpet.111.186981_bib33 article-title: Stimulation of 5-HT2C receptors attenuates cue and cocaine-primed reinstatement of cocaine-seeking behavior in rats publication-title: Behav Pharmacol doi: 10.1097/FBP.0b013e3282f1c94b – volume: 103 start-page: 111 year: 2001 ident: 10.1124/jpet.111.186981_bib13 article-title: m-Chlorophenylpiperazine excites non-dopaminergic neurons in the rat substantia nigra and ventral tegmental area by activating serotonin-2C receptors publication-title: Neuroscience doi: 10.1016/S0306-4522(00)00561-3 – volume: 251 start-page: 142 year: 1989 ident: 10.1124/jpet.111.186981_bib40 article-title: Effects of cocaine and related drugs in nonhuman primates. II. Stimulant effects on schedule-controlled behavior publication-title: J Pharmacol Exp Ther doi: 10.1016/S0022-3565(25)20686-3 – volume: 43 start-page: 407 year: 1986 ident: 10.1124/jpet.111.186981_bib1 article-title: Macaca fascicularis publication-title: Adv Neurol – volume: 33 start-page: 1402 year: 2008 ident: 10.1124/jpet.111.186981_bib19 article-title: The 5-HT2C receptor agonist Ro60–0175 reduces cocaine self-administration and reinstatement induced by the stressor yohimbine, and contextual cues publication-title: Neuropsychopharmacology doi: 10.1038/sj.npp.1301509 – volume: 320 start-page: 627 year: 2007 ident: 10.1124/jpet.111.186981_bib32 article-title: Monoamine releasers with varying selectivity for dopamine/norepinephrine versus serotonin release as candidate “agonist” medications for cocaine dependence: studies in assays of cocaine discrimination and cocaine self-administration in rhesus monkeys publication-title: J Pharmacol Exp Ther doi: 10.1124/jpet.106.107383 – volume: 205 start-page: 337 year: 2009 ident: 10.1124/jpet.111.186981_bib17 article-title: Role of dopamine transporters in the behavioral effects of 3,4-methylenedioxymethamphetamine (MDMA) in nonhuman primates publication-title: Psychopharmacology (Berl) doi: 10.1007/s00213-009-1545-0 – volume: 295 start-page: 1183 year: 2000 ident: 10.1124/jpet.111.186981_bib23 article-title: Studies to investigate the role of 5-HT(2C) receptors on cocaine- and food-maintained behavior publication-title: J Pharmacol Exp Ther doi: 10.1016/S0022-3565(24)39021-4 – volume: 46 start-page: 635 year: 1990 ident: 10.1124/jpet.111.186981_bib35 article-title: Cocaine inhibition of ligand binding at dopamine, norepinephrine and serotonin transporters: a structure-activity study publication-title: Life Sci doi: 10.1016/0024-3205(90)90132-B – volume: 80 start-page: 481 year: 2005 ident: 10.1124/jpet.111.186981_bib21 article-title: Interaction of cocaine and dopamine transporter inhibitors on behavior and neurochemistry in monkeys publication-title: Pharmacol Biochem Behav doi: 10.1016/j.pbb.2005.01.004 – volume: 275 start-page: 1551 year: 1995 ident: 10.1124/jpet.111.186981_bib24 article-title: Serotonergic modulation of the behavioral effects of cocaine in the squirrel monkey publication-title: J Pharmacol Exp Ther doi: 10.1016/S0022-3565(25)12217-9 – volume: 94 start-page: 278 year: 2009 ident: 10.1124/jpet.111.186981_bib26 article-title: Behavioral and neurochemical effects of amphetamine analogs that release monoamines in the squirrel monkey publication-title: Pharmacol Biochem Behav doi: 10.1016/j.pbb.2009.09.007 – volume: 128 start-page: 13 year: 1999 ident: 10.1124/jpet.111.186981_bib34 article-title: Functional characterization of agonists at recombinant human 5-HT2A, 5-HT2B and 5-HT2C receptors in CHO-K1 cells publication-title: Br J Pharmacol doi: 10.1038/sj.bjp.0702751 – volume: 130 start-page: 41 year: 1997 ident: 10.1124/jpet.111.186981_bib43 article-title: Serotonergic mechanisms involved in the discriminative stimulus, reinforcing and subjective effects of cocaine publication-title: Psychopharmacology (Berl) doi: 10.1007/s002130050210 – volume: 5 start-page: 483 year: 2004 ident: 10.1124/jpet.111.186981_bib45 article-title: Dopamine, learning and motivation publication-title: Nat Rev Neurosci doi: 10.1038/nrn1406 – volume: 251 start-page: 150 year: 1989 ident: 10.1124/jpet.111.186981_bib5 article-title: Effects of cocaine and related drugs in nonhuman primates. III. Self-administration by squirrel monkeys publication-title: J Pharmacol Exp Ther doi: 10.1016/S0022-3565(25)20689-9 – volume: 237 start-page: 1219 year: 1987 ident: 10.1124/jpet.111.186981_bib36 article-title: Cocaine receptors on dopamine transporters are related to self-administration of cocaine publication-title: Science doi: 10.1126/science.2820058 – volume: 56 start-page: 129 year: 2005 ident: 10.1124/jpet.111.186981_bib25 article-title: Changes in extracellular dopamine during cocaine self-administration in squirrel monkeys publication-title: Synapse doi: 10.1002/syn.20135 – volume: 42 start-page: 12 year: 2001 ident: 10.1124/jpet.111.186981_bib29 article-title: Regional distribution and cellular localization of 5-HT2C receptor mRNA in monkey brain: comparison with [3H]mesulergine binding sites and choline acetyltransferase mRNA publication-title: Synapse doi: 10.1002/syn.1095 – volume: 94 start-page: 204 year: 2009 ident: 10.1124/jpet.111.186981_bib4 article-title: Interactions between the mGluR2/3 agonist, LY379268, and cocaine on in vivo neurochemistry and behavior in squirrel monkeys publication-title: Pharmacol Biochem Behav doi: 10.1016/j.pbb.2009.08.011 – volume: 86 start-page: 45 year: 2007 ident: 10.1124/jpet.111.186981_bib27 article-title: Faster onset and dopamine transporter selectivity predict stimulant and reinforcing effects of cocaine analogs in squirrel monkeys publication-title: Pharmacol Biochem Behav doi: 10.1016/j.pbb.2006.12.006 – volume: 334 start-page: 642 year: 2010 ident: 10.1124/jpet.111.186981_bib30 article-title: Endocrine and neurochemical effects of 3,4-methylenedioxymethamphetamine and its stereoisomers in rhesus monkeys publication-title: J Pharmacol Exp Ther doi: 10.1124/jpet.110.166595 – volume: 386 start-page: 827 year: 1997 ident: 10.1124/jpet.111.186981_bib41 article-title: Relationship between subjective effects of cocaine and dopamine transporter occupancy publication-title: Nature doi: 10.1038/386827a0 – volume: 32 start-page: 1381 year: 1993 ident: 10.1124/jpet.111.186981_bib3 article-title: m-chlorophenylpiperazine (mCPP) increases extracellular serotonin in the diencephalon of awake rats publication-title: Neuropharmacology doi: 10.1016/0028-3908(93)90034-Z – volume: 148 start-page: 299 year: 2000 ident: 10.1124/jpet.111.186981_bib11 article-title: Cocaine-induced changes in extracellular dopamine determined by microdialysis in awake squirrel monkeys publication-title: Psychopharmacology (Berl) doi: 10.1007/s002130050054 – volume: 64 start-page: 327 year: 1999 ident: 10.1124/jpet.111.186981_bib39 article-title: Pharmacological and environmental determinants of relapse to cocaine-seeking behavior publication-title: Pharmacol Biochem Behav doi: 10.1016/S0091-3057(99)00049-0 – volume: 274 start-page: 1414 year: 1995 ident: 10.1124/jpet.111.186981_bib9 article-title: Modulation of the discriminative stimulus properties of cocaine by 5-HT1B and 5-HT2C receptors publication-title: J Pharmacol Exp Ther doi: 10.1016/S0022-3565(25)10686-1 – volume: 20 start-page: 287 year: 1999 ident: 10.1124/jpet.111.186981_bib16 article-title: Effects of mCPP on the extracellular concentrations of serotonin and dopamine in rat brain publication-title: Neuropsychopharmacology doi: 10.1016/S0893-133X(98)00070-0 – volume: 31 start-page: 149 year: 1993 ident: 10.1124/jpet.111.186981_bib28 article-title: Effects of three monoamine uptake inhibitors on behavior maintained by cocaine or food presentation in rhesus monkeys publication-title: Drug Alcohol Depend doi: 10.1016/0376-8716(93)90067-Z |
| SSID | ssj0014463 |
| Score | 2.3073254 |
| Snippet | Accumulating evidence indicates that the serotonin system modulates the behavioral and neurochemical effects of cocaine, but the receptor subtypes mediating... |
| SourceID | pubmedcentral proquest pubmed crossref elsevier |
| SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 424 |
| SubjectTerms | Animals Behavior, Animal - drug effects Behavioral Pharmacology Caudate Nucleus - drug effects Caudate Nucleus - metabolism Cocaine - pharmacology Dopamine - pharmacology Drug Interactions Ethylamines - pharmacology Indoles - pharmacology Male Microdialysis - methods Nucleus Accumbens - drug effects Nucleus Accumbens - metabolism Piperazines - pharmacology Receptor, Serotonin, 5-HT2C - metabolism Saimiri Self Administration Serotonin 5-HT2 Receptor Agonists - pharmacology |
| Title | Effects of Serotonin 2C Receptor Agonists on the Behavioral and Neurochemical Effects of Cocaine in Squirrel Monkeys |
| URI | https://dx.doi.org/10.1124/jpet.111.186981 https://www.ncbi.nlm.nih.gov/pubmed/22328576 https://www.proquest.com/docview/1001967153 https://pubmed.ncbi.nlm.nih.gov/PMC3336818 |
| Volume | 341 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1da9swFBVZ97KXse9l3YYGowxSZ7akOM5jCe3CaEdhKeTNyJK8FlY7pM5D91_2X3evJdlOusBWCCbYsuzkHknnSvceEfIxCnMc5mQQKckDEWsVZLkUgVRMxyYDolRr6Z19i2cX4utitOj1fneiltZVNlS__ppXch-rwjmwK2bJ_odlm0rhBHwH-8IRLAzHf7LxcRuMAW2-rHBqdWC5oFmCMz04-lGiMq5fEvBqiCsnEFArcygvGdCpbQoj3JXVE_mOocIrjH8tC2jwN1022-aV1Yx22cpgW1Wnje0DOpleDY8_kwX0VJdtrvvgZNhGBVxf2xCCmaWpg9Pm2qz0wdynBlyJlfbX3PwFBoKMuvMXTWLNRtynSzKw20j4jppbiSyHSNbpdoXNw3YjuLDTo3cHByZwcABvBAeKIW7GZbeL2VLcxgVshg8HdpMAwRMPyEMGXghukPFl0UQQoSfNGzF6KO6Uo-Axn7cesov03HVqtmNzO2Rn_oQ8djalRxZyT0nPFM_Iwbm17-0hnXdseUgP6HnH8s9J5ZBEy5w2uKRsSj0uqcclLQsKpqUtLinghm7gknZqc7ikUJ3HJXW4fEEuTo7n01ngdvcIlBC8CiZSKyZUlPFIRXxkwnySw0eGoZY64TmT-USysYy0iXiehRqXDMUo00A4gWEx_pLsFWVhXhOaxHoCFeWZ0lJk8RjKGK5GGnzp0CRR3idD__enyknf4w4sP9PaBWYiRXuhM5xae_XJp-aGpVV92V2UeXumjrRaMpoC7Hbf9MFbPoXuHNfoZGHK9Q1KiMOYOAYe0ievLBKaNwBQsgR-U5-MNzDSFECp-M0rxdVlLRnPOY-Bmr-5z8vuk0dtu31L9qrV2rwDJl5l7-v28AejuuWV |
| linkProvider | Geneva Foundation for Medical Education and Research |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Effects+of+Serotonin+2C+Receptor+Agonists+on+the+Behavioral+and+Neurochemical+Effects+of+Cocaine+in+Squirrel+Monkeys&rft.jtitle=The+Journal+of+pharmacology+and+experimental+therapeutics&rft.au=Manvich%2C+Daniel+F.&rft.au=Kimmel%2C+Heather+L.&rft.au=Howell%2C+Leonard+L.&rft.date=2012-05-01&rft.pub=Elsevier+Inc&rft.issn=0022-3565&rft.volume=341&rft.issue=2&rft.spage=424&rft.epage=434&rft_id=info:doi/10.1124%2Fjpet.111.186981&rft.externalDocID=S0022356524181724 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0022-3565&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0022-3565&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0022-3565&client=summon |